PALI - PALISADE BIO, INC.
0.8348
0.048 5.726%
Share volume: 1,152,721
Last Updated: 05-06-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.08%
PREVIOUS CLOSE
CHG
CHG%
$0.79
0.05
0.06%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-13-2024 | 08-10-2023 | 11-09-2023 | 11-12-2024 | 05-13-2024 | 08-12-2024 | 11-12-2024 | 03-24-2025 | |
| Total revenue | 250.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 250.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -100.00% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 2.779 M | 3.609 M | 3.778 M | 2.929 M | 3.673 M | 4.211 M | 3.593 M | 3.382 M | |
| Selling general and admin | 1.538 M | 1.432 M | 1.674 M | 1.558 M | 1.459 M | 1.583 M | 1.456 M | 1.298 M | |
| Research and development | 1.241 M | 2.177 M | 2.104 M | 1.371 M | 2.214 M | 2.628 M | 2.137 M | 2.084 M | |
| Total expenses | 2.779 M | 3.609 M | 3.778 M | 3.154 M | 3.673 M | 4.211 M | 3.593 M | 3.382 M | |
| 29.87% | 4.68% | -16.52% | 16.46% | 14.65% | -14.68% | -5.87% | |||
| Operating income | -2.529 M | -3.609 M | -3.778 M | -3.154 M | -3.673 M | -4.211 M | -3.593 M | -3.382 M | |
| Ebit | -2.340 M | -3.390 M | -3.588 M | -2.967 M | -3.526 M | -4.078 M | -3.481 M | -3.341 M | |
| Pretax income | -2.340 M | -3.393 M | -3.596 M | -2.971 M | -3.527 M | -4.080 M | -3.487 M | -3.344 M | |
| 45.00% | 5.98% | -17.38% | 18.71% | 15.68% | -14.53% | -4.10% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.340 M | -3.393 M | -3.596 M | -2.971 M | -3.527 M | -4.080 M | -3.487 M | -3.344 M | |
| -45.00% | -5.98% | 17.38% | -18.71% | -15.68% | 14.53% | 4.10% |
